ReviewFrontiers in immunology2026
OxLDL-induced ferroptosis and pyroptosis in atherosclerosis: a mini review.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting integrated cell death networks in sepsis‑associated acute kidney injury: Shared regulatory nodes and diet‑related small molecule modulation (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidized low-density lipoprotein (oxLDL) is a central driver of inflammatory responses in atherosclerosis and triggers multiple forms of regulated cell death beyond classical apoptosis. Ferroptosis, characterized by iron-dependent lipid peroxidation (LPO), and pyroptosis, mediated by inflammasome-activated gasdermin D (GSDMD) pore formation, have emerged as critical contributors to plaque progression and instability. Recent evidence highlights a significant crosstalk between these two death modalities: the N-terminal fragment of GSDMD targets mitochondrial membranes to promote LPO, while ferroptotic byproducts-including oxidized phospholipids and 4-hydroxynonenal-activate the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome. This bidirectional interplay establishes a positive feedback loop that amplifies vascular inflammation. This review summarizes the molecular mechanisms underlying oxLDL-induced ferroptosis and pyroptosis, emphasizes their interconnected regulatory networks, and discusses therapeutic strategies targeting this cell death axis. Understanding this integrated cell death network may provide new insights for resolving residual inflammatory risk in atherosclerotic cardiovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.